Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Apr 7;2019:5421985. doi: 10.1155/2019/5421985

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2019 Yao Xiao et al.

This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

The TMIGD2 expression level was increased in recurrent OSCC. (a) Hematoxylin and eosin (HE) staining with TMIGD2 immunostaining of primary OSCC and recurrent OSCC. (b) There was no significant difference in the HHLA2 expression levels between primary OSCC and recurrent OSCC. (c) The TMIGD2 expression level was significantly increased in recurrent OSCC compared with primary OSCC. (d) There was no significant difference in the HHLA2 expression levels between primary OSCC and OSCC after TPF therapy. (e) There was no significant difference in the TMIGD2 expression levels between primary OSCC and OSCC after TPF therapy. (f) There was no significant change in the HHLA2 expression level in OSCC after radiotherapy compared with primary OSCC. (g) There was no significant change in the TMIGD2 expression level in OSCC after radiotherapy compared with primary OSCC.